Tower View Wealth Management’s Biogen BIIB Stock Holding History

Tower View Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-29	Closed	-$6.27K	–	193
2026 Q2	$6.27K	Hold	29	–	–	﹤0.01%	173
2026 Q1	$5.32K	Hold	29	–	–	﹤0.01%	172
2025 Q4	$5.1K	Hold	29	–	–	﹤0.01%	156
2025 Q3	$4.06K	Hold	29	–	–	﹤0.01%	157
2025 Q2	$3.64K	Hold	29	–	–	﹤0.01%	179
2025 Q1	$3.97K	Hold	29	–	–	﹤0.01%	165
2024 Q4	$4.44K	Hold	29	–	–	﹤0.01%	159
2024 Q3	$5.62K	Hold	29	–	–	﹤0.01%	156
2024 Q2	$6.72K	Hold	29	–	–	﹤0.01%	145
2024 Q1	$6.25K	Hold	29	–	–	﹤0.01%	151
2023 Q4	$8K	Hold	29	–	–	0.01%	129
2023 Q3	$7K	Hold	29	–	–	﹤0.01%	127
2023 Q2	$8K	Hold	29	–	–	0.01%	126
2023 Q1	$8K	Hold	29	–	–	0.01%	120
2022 Q4	$8K	Hold	29	–	–	0.01%	125
2022 Q3	$8K	Hold	29	–	–	0.01%	123
2022 Q2	$6K	Hold	29	–	–	﹤0.01%	130
2022 Q1	$6K	Hold	29	–	–	﹤0.01%	159
2021 Q4	$7K	Hold	29	–	–	﹤0.01%	164
2021 Q3	$8K	Hold	29	–	–	﹤0.01%	190
2021 Q2	$10K	Hold	29	–	–	0.01%	131
2021 Q1	$8K	Hold	29	–	–	﹤0.01%	140
2020 Q4	$7K	Hold	29	–	–	﹤0.01%	146
2020 Q3	$8K	Hold	29	–	–	0.01%	117
2020 Q2	$8K	Hold	29	–	–	0.01%	108
2020 Q1	$9K	Hold	29	–	–	0.01%	91
2019 Q4	$9K	Hold	29	–	–	0.01%	116
2019 Q3	$7K	Hold	29	–	–	0.01%	115
2019 Q2	$7K	Hold	29	–	–	0.01%	111
2019 Q1	$7K	Hold	29	–	–	0.01%	118
2018 Q4	$9K	Hold	29	–	–	0.01%	111
2018 Q3	$10K	Buy	+29	New	+$10K	0.01%	128

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Adams Diversified Equity Fund Baltimore, Maryland $3.3B AUM 38.12% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

Tower View Wealth Management's BIIB Position: Q3 2026 in Review

Tower View Wealth Management sold out of Biogen (BIIB) in Q3 2026, closing a stake of 29 shares — an estimated $6.27K sold.

Tower View Wealth Management first reported a position in BIIB in Q3 2018 and held it in 32 quarters. The position peaked at $10K in Q2 2021. 232 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

Tower View Wealth Management reported no remaining Biogen position as of Q3 2026 after selling out during the quarter.
Tower View Wealth Management sold 29 Biogen shares in Q3 2026, an estimated $6.27K.
Tower View Wealth Management first reported a position in Biogen in Q3 2018 and held it in 32 quarters.
Tower View Wealth Management's Biogen position peaked at $10K in Q2 2021.
232 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Tower View Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.